| [1] |
Shuang HAN,Jingwen HUANG,Yue SHI,Xinyue HUANG,Mengru GUO,Yi ZHENG,Ning MA.
Network pharmacology analysis of mechanism of Taohong Siwu Decoction in treating periodontitis and its in vitro experimental validation
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 703-718.
|
| [2] |
Xin LIU,Yuyang ZHANG,Deling ZENG,Xiaoqin LIU,Lu ZHANG,Meiying LI,Hong CHEN,Bangrong CAO,Shiqi MA.
Levels of KLRG1 +NK cells in peripheral blood of NSCLC patients and their clinical significances
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 746-754.
|
| [3] |
Gengfei CAO, SHAYA·Mahati,Junpeng GU,Weizheng JI, ASIHAER·Hasimu,Weixin REN.
Differences in immune microenvironment between DEB-TACE and c-TACE in treatment of hepatocellular carcinoma and mechanism of TRADD-mediated Th17 differentiation
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 764-780.
|
| [4] |
Xiaohui LIANG,Wenna LIU,Jianbo ZHAO.
Bioinformatic analysis on PAQR3 expression in hepatocellular carcinoma and its correlations with T lymphocyte infiltration, immune checkpoint genes, and patient survival
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 781-790.
|
| [5] |
Jiaxiang ZHANG,Yang CAO,Chen HUAN.
Research progress in impact of post-translational modifications of HIV-1 Tat protein on regulatory mechanisms of HIV-1 transcription and replication
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 854-862.
|
| [6] |
Qiuping SU,Lei XING,Wei ZHANG,Shan JIANG,Yangyang ZHAO,Fangfang CHEN.
Research progress in anti-tumor mechanism of berberine and application of its novel nano-delivery system in tumor therapy
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 863-871.
|
| [7] |
Jingyuan WANG,Fang CHEN,Yancun LIU,Shixin LI,Songtao SHOU.
Protective effect of silencing coagulation factor V gene on septic rats by inhibiting JNK1/2 and p38 MAPK signaling pathways
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 418-428.
|
| [8] |
Jiulin YOU,Liangshu FENG,Xin LI,Xinyu WANG,Shuang WANG,Mingqin ZHU,Lingmin ZHAO,Xingqi SU,Jing WANG,Jiachun FENG,Chuan WANG,Di MA.
Changes in serum cytokine levels, immune status and risk factor analysis in patients with acute ischemic stroke
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 499-506.
|
| [9] |
Tian LI,Jiafeng WANG,Zhimin ZHANG.
Research progress in application of exosomes in diagnosis and treatment of oral diseases
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 543-550.
|
| [10] |
Huiying YANG,Weihong LIANG,Xinru XU,Haodan SUN,Xin JIAO,Haiping WANG.
Research progress in effect of bone marrow mesenchymal stem cells on differentiation induction of cardiomyocyte-like cells, protection of cardiomyocytes, and myocardial-related diseases
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 281-289.
|
| [11] |
Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG.
UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69.
|
| [12] |
Xiao LIN,Meng ZHOU,Fan LIN,Xiujuan YAO.
Bioinformatics analysis and experimental validation of fatty acid metabolism-related genes in idiopathic pulmonary fibrosis tissue
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 93-104.
|
| [13] |
Luyao WANG,Chenxi ZHAO,Jincheng DU,Linlin LIU.
Research progress in effect of Toll-like receptor 7/8 on occurrence and development of tumor
[J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 264-271.
|
| [14] |
Limei WEN,Yali GUO,Wenmei MA,Taotao XUE,Ruoyu GENG,Chong MA,Xinhong ZHANG,Jianhua YANG.
Bioinformatic analysis of TCGA database based on INPP4B gene expression in hepatocellular carcinoma and its experimental validation
[J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1618-1629.
|
| [15] |
Tao SUN,Zhiyin DAI,Xuan LI,Chaopu ZHANG,Shu DING,Jianwei ZHAO.
Predictive value of pan-immune-inflammation index for major adverse cardiovascular events within 1 year after PCI in elderly patients with coronary heart disease
[J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1655-1660.
|